Although the isolated VHH that bind to gD2 are unable to neutralize HSV-2 on their own in a monomeric form, they can be used to specifically deliver other effector proteins resulting in potent antiviral activity against HSV-2.
This strategy resulted in the isolation of a highly specific monoclonal antibody (MAb), called CAP88-CH06, that neutralized the CAP88 transmitted/founder virus and viruses from acute infection but was unable to neutralize CAP88 viruses isolated at 6 and 12 months postinfection.
After a near four-hour artillery duel and sustaining numerous hits overall, the flotilla was unable to neutralize the fortification and had to turn back.
In contrast, antisera to HAdV-D37 was unable to neutralize HAdV-D53 at a dilution of equal to or less than 1∶8.
The addition of 50 µM guanosine was unable to neutralize the RBV effect in these 4 cell lines even when the RBV concentration was lowered to 200 or 100 µM (data not shown).
Although anti-P56/75 anti-P56/75le to neutralize HPV45, a concatemer, designated L2 11–88×5, wasch is composed of the conserved N-terminal sequnableof amino acids 11–88 from L2 protoineutralizedistantly related HPV45ypes 1, 5, 6, 16, and 18 did induconcatemeries in both mice andesignated
The disadvantage of these approaches is that they were unable to capture or neutralize the VEGF protein that is already circulating in the system.
